Veristat Congratulates TESARO on the FDA Approval of ZEJULA™
SOUTHBOROUGH, MA – May 30, 2017 – Veristat, a full service Clinical Research Organization (CRO), congratulates TESARO, Inc. on the...
Veristat Acknowledged on Boston Business Journal’s “Fast 50” List for a Second Consecutive...
Ranked as one of the Top 50 Fastest Growing Private Companies in Massachusetts